loadpatents
name:-0.034149885177612
name:-0.026461124420166
name:-0.0025649070739746
Bury; Paul Stanley Patent Filings

Bury; Paul Stanley

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bury; Paul Stanley.The latest application filed is for "process for the preparation of a boron-substituted porphyrin".

Company Profile
0.19.28
  • Bury; Paul Stanley - Bishop's Stortford GB
  • Bury; Paul Stanley - Hertfordshire GB
  • Bury; Paul Stanley - Burnley GB
  • Bury; Paul Stanley - Kobenhavn DK
  • Bury; Paul Stanley - Lancashire GB
  • Bury; Paul Stanley - K.o slashed.benhavn DK
  • Bury; Paul Stanley - Copenhagen NV DK
  • Bury; Paul Stanley - Copenhagen DK
  • Bury; Paul Stanley - K.o slashed.benhavn NV DK
  • Bury, Paul Stanley - Kobenhavn NV DK
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Process for the preparation of a boron-substituted porphyrin
Grant 8,680,265 - Bury , et al. March 25, 2
2014-03-25
Process For The Preparation Of A Boron-substituted Porphyrin
App 20100016613 - Bury; Paul Stanley ;   et al.
2010-01-21
Compounds, their preparation and use
Grant 7,220,877 - Sauerberg , et al. May 22, 2
2007-05-22
Combination therapy using a dual PPAR-.alpha./PPAR-.gamma. activator and a GLP-1 derivative for the treatment of metabolic syndrome and related diseases and disorders
Grant 7,202,213 - Mogensen , et al. April 10, 2
2007-04-10
Compounds, their preparation and use
Grant 7,067,530 - Jeppesen , et al. June 27, 2
2006-06-27
Compounds, their preparation and use
Grant 6,972,294 - Murray , et al. December 6, 2
2005-12-06
Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives
Grant 6,869,967 - Jeppesen , et al. March 22, 2
2005-03-22
Compounds, their preparation and use
Grant 6,867,218 - Mogensen , et al. March 15, 2
2005-03-15
Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
App 20040229899 - Jeppesen, Lone ;   et al.
2004-11-18
Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
Grant 6,723,731 - Jeppesen , et al. April 20, 2
2004-04-20
Compounds, their preparation and use
Grant 6,703,401 - Jeppesen , et al. March 9, 2
2004-03-09
Compounds, their preparation and use
Grant 6,683,111 - Jeppesen , et al. January 27, 2
2004-01-27
Combination therapy using a dual PPAR-a/PPAR-y activator and a GLP-1 derivative for the treatment of metabolic syndrome and related diseases and disorders
App 20030199451 - Mogensen, John Patrick ;   et al.
2003-10-23
Compounds, their preparation and use
App 20030195200 - Mogensen, John Patrick ;   et al.
2003-10-16
New compounds, their preparation and use
App 20030171358 - Jeppesen, Lone ;   et al.
2003-09-11
Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
Grant 6,602,901 - Jeppesen , et al. August 5, 2
2003-08-05
Novel compounds, their preparation and use
App 20030139473 - Jeppesen, Lone ;   et al.
2003-07-24
Novel compounds, their preparation and use
App 20030109560 - Jeppesen, Lone ;   et al.
2003-06-12
Novel compounds, their preparation and use
App 20030109579 - Sauerberg, Per ;   et al.
2003-06-12
Novel compounds, their preparation and use
App 20030055076 - Jeppesen, Lone ;   et al.
2003-03-20
Process for the preparation of substituted 3-phenyl-propanoic acid esters and substituted 3-phenyl-propanoic acids
App 20030008361 - Ebdrup, Soren ;   et al.
2003-01-09
Substituted hetero-polycyclic compounds as PPAR.alpha. and PPAR.gamma. activators
Grant 6,468,996 - Jeppesen , et al. October 22, 2
2002-10-22
New compounds, their preparation and use
App 20020128260 - Jeppesen, Lone ;   et al.
2002-09-12
Substituted hetero-polycyclic compounds as PPARalpha and PPARgamma
App 20020115657 - Jeppesen, Lone ;   et al.
2002-08-22
New compounds, their preparation and use
App 20020115654 - Jeppesen, Lone ;   et al.
2002-08-22
Substituted hetero-polycyclic compounds as PPARalpha and PPARgamma activators
App 20020111344 - Jeppesen, Lone ;   et al.
2002-08-15
Substituted hetero-polycyclic compounds as PPARalpha and PPARgamma activators
App 20020103188 - Jeppesen, Lone ;   et al.
2002-08-01
New compounds, their preparation and use
App 20020065268 - Jeppesen, Lone ;   et al.
2002-05-30
Compounds, their preparation and use
App 20020065267 - Jeppesen, Lone ;   et al.
2002-05-30
New compounds, their preparation and use
App 20020061880 - Jeppesen, Lone ;   et al.
2002-05-23
Compounds, their preparation and use
App 20020061876 - Jeppesen, Lone ;   et al.
2002-05-23
New compounds, their preparation and use
App 20020055502 - Jeppesen, Lone ;   et al.
2002-05-09
New compounds, their preparation and use
App 20020022656 - Sauerberg, Per ;   et al.
2002-02-21
New compounds, their preparation and use
App 20020010171 - Jeppesen, Lone ;   et al.
2002-01-24
New compounds, their preparation and use
App 20010041709 - Mogensen, John Patrick ;   et al.
2001-11-15
cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
Grant 6,316,494 - Jacobsen , et al. November 13, 2
2001-11-13
Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors(PPAR)
App 20010031764 - Jeppesen, Lone ;   et al.
2001-10-18
Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
App 20010031762 - Jeppesen, Lone ;   et al.
2001-10-18
Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
App 20010031786 - Jeppesen, Lone ;   et al.
2001-10-18
New compounds, their preparation and use
App 20010029256 - Jeppesen, Lone ;   et al.
2001-10-11
Novel Cis-3,4-chroman Derivatives Useful In The Prevention Or Treatment Of Estrogen Related Diseases Or Syndromes
App 20010021710 - JACOBSEN, POUL ;   et al.
2001-09-13
Compounds, their preparation and use
Grant 6,274,608 - Sauerberg , et al. August 14, 2
2001-08-14
cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
Grant 6,043,269 - Jacobsen , et al. March 28, 2
2000-03-28
(+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes
Grant 5,985,306 - Jacobsen , et al. November 16, 1
1999-11-16
Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
Grant 5,958,967 - Jacobsen , et al. September 28, 1
1999-09-28
Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
Grant 5,919,817 - Jacobsen , et al. July 6, 1
1999-07-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed